Inderjit Jabbal‐Gill

2.6k total citations · 1 hit paper
20 papers, 2.0k citations indexed

About

Inderjit Jabbal‐Gill is a scholar working on Pharmaceutical Science, Epidemiology and Immunology. According to data from OpenAlex, Inderjit Jabbal‐Gill has authored 20 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmaceutical Science, 6 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Inderjit Jabbal‐Gill's work include Advanced Drug Delivery Systems (11 papers), Immunotherapy and Immune Responses (5 papers) and Influenza Virus Research Studies (4 papers). Inderjit Jabbal‐Gill is often cited by papers focused on Advanced Drug Delivery Systems (11 papers), Immunotherapy and Immune Responses (5 papers) and Influenza Virus Research Studies (4 papers). Inderjit Jabbal‐Gill collaborates with scholars based in United Kingdom, Norway and Italy. Inderjit Jabbal‐Gill's co-authors include Lisbeth Illum, A.N. Fisher, M. Hinchcliffe, S.S. Davis, Peter Watts, Alan M. Smith, Richard Nankervis, S.S. Davis, Rino Rappuoli and A. M. Dyer and has published in prestigious journals such as Advanced Drug Delivery Reviews, Infection and Immunity and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Inderjit Jabbal‐Gill

20 papers receiving 1.9k citations

Hit Papers

Chitosan as a novel nasal delivery system for vaccines 2001 2026 2009 2017 2001 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inderjit Jabbal‐Gill United Kingdom 19 1.1k 723 560 330 319 20 2.0k
Martin J. D’Souza United States 24 725 0.7× 542 0.7× 591 1.1× 302 0.9× 199 0.6× 130 2.0k
Jonathan A. Meulbroek United States 14 623 0.6× 683 0.9× 507 0.9× 270 0.8× 177 0.6× 17 2.0k
Jay K. Staas United States 16 830 0.8× 699 1.0× 726 1.3× 395 1.2× 222 0.7× 20 2.2k
M. Hinchcliffe United Kingdom 10 803 0.7× 492 0.7× 252 0.5× 159 0.5× 233 0.7× 11 1.4k
Vincent W. Bramwell United Kingdom 22 426 0.4× 905 1.3× 917 1.6× 230 0.7× 145 0.5× 32 1.8k
H. Jeffery United Kingdom 9 641 0.6× 432 0.6× 365 0.7× 143 0.4× 233 0.7× 10 1.3k
Kevin O. Kisich United States 17 254 0.2× 714 1.0× 644 1.1× 237 0.7× 263 0.8× 24 2.4k
I.M. van der Lubben Netherlands 7 565 0.5× 333 0.5× 233 0.4× 143 0.4× 253 0.8× 9 1.0k
Maytal Bivas‐Benita Israel 18 370 0.3× 397 0.5× 484 0.9× 198 0.6× 137 0.4× 29 1.5k
Suzanne M. Bal Netherlands 29 1.2k 1.1× 556 0.8× 1.7k 3.0× 176 0.5× 103 0.3× 36 3.0k

Countries citing papers authored by Inderjit Jabbal‐Gill

Since Specialization
Citations

This map shows the geographic impact of Inderjit Jabbal‐Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inderjit Jabbal‐Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inderjit Jabbal‐Gill more than expected).

Fields of papers citing papers by Inderjit Jabbal‐Gill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inderjit Jabbal‐Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inderjit Jabbal‐Gill. The network helps show where Inderjit Jabbal‐Gill may publish in the future.

Co-authorship network of co-authors of Inderjit Jabbal‐Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Inderjit Jabbal‐Gill. A scholar is included among the top collaborators of Inderjit Jabbal‐Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inderjit Jabbal‐Gill. Inderjit Jabbal‐Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pedersen, Gabriel Kristian, Rishi D. Pathirana, Geir Bredholt, et al.. (2012). A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine. Influenza and Other Respiratory Viruses. 7(6). 1181–1193. 31 indexed citations
2.
Jabbal‐Gill, Inderjit, Peter Watts, & Alan M. Smith. (2012). Chitosan-based delivery systems for mucosal vaccines. Expert Opinion on Drug Delivery. 9(9). 1051–1067. 81 indexed citations
3.
Jul‐Larsen, Åsne, Rishi D. Pathirana, Abdullah S. Madhun, et al.. (2011). The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine. Influenza and Other Respiratory Viruses. 6(2). 90–100. 27 indexed citations
4.
Jabbal‐Gill, Inderjit. (2010). Nasal vaccine innovation. Journal of drug targeting. 18(10). 771–786. 70 indexed citations
5.
Cheng, Yuhui, A. M. Dyer, Inderjit Jabbal‐Gill, et al.. (2005). Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations. European Journal of Pharmaceutical Sciences. 26(1). 9–15. 40 indexed citations
6.
Read, Robert C., Simone Naylor, C. W. Potter, et al.. (2005). Effective nasal influenza vaccine delivery using chitosan. Vaccine. 23(35). 4367–4374. 145 indexed citations
7.
Hinchcliffe, Michael, Inderjit Jabbal‐Gill, & Alan M. Smith. (2005). Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep. Journal of Pharmacy and Pharmacology. 57(6). 681–687. 27 indexed citations
9.
Iqbal, Muhammad Farooq, Wei Lin, Inderjit Jabbal‐Gill, et al.. (2003). Nasal delivery of chitosan–DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice. Vaccine. 21(13-14). 1478–1485. 98 indexed citations
10.
11.
Illum, Lisbeth, Peter Watts, A.N. Fisher, et al.. (2002). Intranasal Delivery of Morphine. Journal of Pharmacology and Experimental Therapeutics. 301(1). 391–400. 113 indexed citations
12.
Dyer, A. M., M. Hinchcliffe, Peter Watts, et al.. (2002). Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles. Pharmaceutical Research. 19(7). 998–1008. 217 indexed citations
13.
Illum, Lisbeth, A.N. Fisher, Inderjit Jabbal‐Gill, & S.S. Davis. (2001). Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides. International Journal of Pharmaceutics. 222(1). 109–119. 86 indexed citations
14.
Jabbal‐Gill, Inderjit, Lin Wu, Otfried Kistner, Stanley S. Davis, & Lisbeth Illum. (2001). Polymeric lamellar substrate particles for intranasal vaccination. Advanced Drug Delivery Reviews. 51(1-3). 97–111. 24 indexed citations
15.
Illum, Lisbeth, Inderjit Jabbal‐Gill, M. Hinchcliffe, A.N. Fisher, & S.S. Davis. (2001). Chitosan as a novel nasal delivery system for vaccines. Advanced Drug Delivery Reviews. 51(1-3). 81–96. 570 indexed citations breakdown →
16.
Bacon, Andrew, J. Makin, Inderjit Jabbal‐Gill, et al.. (2000). Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine Antigens. Infection and Immunity. 68(10). 5764–5770. 122 indexed citations
17.
Jabbal‐Gill, Inderjit, Lin Wu, Peter Watts, et al.. (1999). Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines. Vaccine. 18(3-4). 238–250. 41 indexed citations
18.
Jabbal‐Gill, Inderjit, A.N. Fisher, Rino Rappuoli, Stanley S. Davis, & Lisbeth Illum. (1998). Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice. Vaccine. 16(20). 2039–2046. 100 indexed citations
19.
Fisher, A.N., Nidal F. Farraj, Derek T. O’Hagan, et al.. (1991). Effect of L-α-lysophosphatidylcholine on the nasal absorption of human growth hormone in three animal species. International Journal of Pharmaceutics. 74(2-3). 147–156. 28 indexed citations
20.
Jabbal‐Gill, Inderjit, et al.. (1982). Effect of S-Carboxymethylcysteine on the Biophysical and Biochemical Properties of Mucus in Chronic Bronchitics. Advances in experimental medicine and biology. 144. 423–429. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026